Emerging Markets Earnings: BMS Eyes HCV In Japan, China HIV Sales Slow
This article was originally published in PharmAsia News
Executive Summary
Bristol-Myers Squibb provides few insights into emerging markets earnings, though it fills in some color on HCV in Japan and China HIV sales.